You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 29 No. 4, October 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Herpesvirus hominis Encephalitis

Virus Isolation From Brain Biopsy in Seven Patients and Results of Therapy

Felix A. Sarubbi, Jr., MD; P. Frederick Sparling, MD; W. Paul Glezen, MD

Arch Neurol. 1973;29(4):268-273.


Abstract

Recent experience suggests that Herpesvirus hominis is the commonest cause of sporadic necrotizing encephalitis in man. We documented H hominis encephalitis in seven patients aged 8 months to 70 years. Five of these seven patients were admitted to our hospital in a 13-month period of time. Four patients were treated with idoxuridine, and three of these died. One patient who received a full course of idoxuridine yielded H hominis from postmortem brain samples in titers approximately equal to those found in the pretreatment brain biopsy specimen. The lone survivor was left with significant neurological deficits. Two patients were treated with cytarabine and, although they remain alive, both are hospitalized in chronic care institutions. The duration and severity of illness manifest by these patients may have adversely affected the outcome of therapy.



Author Affiliations

Chapel Hill, NC

From the departments of medicine and bacteriology (Drs. Sarubbi and Sparling), and pediatrics (Dr. Glezen), University of North Carolina School of Medicine, Chapel Hill, NC.


Footnotes

Accepted for publication May 31, 1973.

Reprint requests to departments of medicine and bacteriology, University of North Carolina School of Medicine, Chapel Hill, NC 27514 (Dr. Sarubbi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome
McGrath et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:321-326.
ABSTRACT | FULL TEXT  

Duration of Vidarabine Therapy in Biopsy-Negative Herpes Simplex Encephalitis
Landry et al.
JAMA 1982;247:332-334.
ABSTRACT  

Herpes Simplex Virus Encephalitis New Diagnostic and Clinical Features and Results of Therapy
Koskiniemi et al.
Arch Neurol 1980;37:763-767.
ABSTRACT  

The Decision to Biopsy, Treat, or Wait in Suspected Herpes Encephalitis
BARZA and PAUKER
ANN INTERN MED 1980;92:641-649.
ABSTRACT  

Cerebrospinal Fluid IgG Level in Herpes Simplex Encephalitis
Carroll and Booss
JAMA 1976;236:2092-2093.
ABSTRACT  

Herpes Simplex Encephalitis: Prognosis and Long-Term Follow-Up
Elian
Arch Neurol 1975;32:39-43.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.